Rice Hall James & Associates LLC Has $6.58 Million Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Rice Hall James & Associates LLC boosted its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 3.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 554,202 shares of the construction company’s stock after buying an additional 19,089 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Aspen Aerogels were worth $6,584,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Franklin Resources Inc. lifted its holdings in Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock worth $815,000 after buying an additional 1,483 shares during the period. Greenwood Capital Associates LLC lifted its holdings in Aspen Aerogels by 5.0% during the 4th quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock worth $439,000 after buying an additional 1,749 shares during the period. Rhumbline Advisers lifted its holdings in Aspen Aerogels by 2.8% during the 4th quarter. Rhumbline Advisers now owns 93,044 shares of the construction company’s stock worth $1,105,000 after buying an additional 2,554 shares during the period. Ballentine Partners LLC lifted its stake in shares of Aspen Aerogels by 19.2% in the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock valued at $189,000 after purchasing an additional 2,565 shares during the period. Finally, Bridgewater Advisors Inc. lifted its stake in shares of Aspen Aerogels by 6.5% in the 4th quarter. Bridgewater Advisors Inc. now owns 82,352 shares of the construction company’s stock valued at $1,027,000 after purchasing an additional 4,995 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock opened at $8.67 on Tuesday. Aspen Aerogels, Inc. has a one year low of $8.25 and a one year high of $33.15. The firm has a market capitalization of $711.05 million, a price-to-earnings ratio of 867.47 and a beta of 2.14. The business has a 50-day simple moving average of $12.17 and a 200 day simple moving average of $18.45. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, research analysts anticipate that Aspen Aerogels, Inc. will post 0.12 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ASPN shares. Roth Mkm dropped their price objective on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday. Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday. Craig Hallum dropped their price objective on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday. Piper Sandler dropped their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, Barclays dropped their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $24.67.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.